Why ARCH Venture is Investing in the Future of Biotech

The healthcare industry is constantly evolving, adopting new technologies to provide optimized patient care. ARCH Venture Partners’ Robert Nelsen tells Michael Bancroft about the challenges of investing in the biotech space and some of the upcoming technologies that are revolutionizing disease discovery and healthcare treatments.